Literature DB >> 28062424

Hyperbaric oxygen therapy in the management of severe leg ulcers from prolidase deficiency.

Michelangelo Vestita1, Giuseppe Giudice1, Domenico Bonamonte2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28062424      PMCID： PMC5256565          DOI： 10.1136/bcr-2016-217329

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  Ulceration in Prolidase Deficiency: Successful Treatment with Anticoagulants.

Authors:  Kira Süßmuth; Dieter Metze; Ana-Maria Muresan; Kai Lehmberg; Udo Zur Stadt; Carsten Speckmann; Julien Heinrich Park; Thorsten Marquardt; Vinzenz Oji; Tobias Goerge
Journal:  Acta Derm Venereol       Date:  2020-01-07       Impact factor: 3.875

Review 2.  Clinical Genetics of Prolidase Deficiency: An Updated Review.

Authors:  Marta Spodenkiewicz; Michel Spodenkiewicz; Maureen Cleary; Marie Massier; Giorgos Fitsialos; Vincent Cottin; Guillaume Jouret; Céline Poirsier; Martine Doco-Fenzy; Anne-Sophie Lèbre
Journal:  Biology (Basel)       Date:  2020-05-21

3.  Quantitative analysis of the natural history of prolidase deficiency: description of 17 families and systematic review of published cases.

Authors:  Francis Rossignol; Marvid S Duarte Moreno; Carlos R Ferreira; Manuel Schiff; Jean-François Benoist; Manfred Boehm; Emmanuelle Bourrat; Aline Cano; Brigitte Chabrol; Claudine Cosson; José Luís Dapena Díaz; Arthur D'Harlingue; David Dimmock; Alexandra F Freeman; María Tallón García; Cheryl Garganta; Tobias Goerge; Sara S Halbach; Jan de Laffolie; Christina T Lam; Ludovic Martin; Esmeralda Martins; Andrea Meinhardt; Isabelle Melki; Amanda K Ombrello; Noémie Pérez; Dulce Quelhas; Anna Scott; Anne M Slavotinek; Ana Rita Soares; Sarah L Stein; Kira Süßmuth; Jenny Thies
Journal:  Genet Med       Date:  2021-05-26       Impact factor: 8.822
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.